In response to recent cyber security breaches in Australia, the eConsent for Genomics solution allows individuals to store and share their genomics data and prevent it from being stolen and misused. The solution will be built on Haventec’s patented privacy platforms (Authenticate and Sanctum) which ensures digital identities and sensitive data are always protected. 

Haventec CEO, Dave Maunsell, said that eConsent for Genomics will provide individuals with more control over how their personal health data is used and shared, without compromising their right to privacy. “In simple terms, Haventec’s platform reduces the exposure to risk. We have solved the paradox of keeping sensitive data safe, while supporting increasing demands, and consumer expectations, for openness, connectivity, performance and privacy. “Data and identity are the key foundations for trust across the connected health ecosystem. Our digital consent offering is relevant to any health and wellbeing enterprise and their customers who have a need to confidently and securely store and share personal, sensitive and regulated health information.” Mark Grosser, CEO of 23Strands said the digital transformation of the health sector is unprecedented and organisations are now dependent on digital patient engagement. “An e-consent platform like this will benefit the entire industry and will make individual patients’ lives easier. This is nowhere more evident than in patients and families going through COVID-19, with carers no longer even able to visit their sick family in ICU wards. We are collaborating with Haventec to ensure seamless and secure communication and consent can be delivered to all stakeholders at every level of care. “The information managed in this pilot platform includes; patient personal information, patient consent instructions, patient medical analysis, diagnostics and test reports. We provide genome analysis of DNA and our platform correlates outcomes for patients based on medical, clinical and genetics analysis. This new and exciting project with Haventec will be linked to our service as a core platform for us to manage the storage and sharing of the genetic analysis reports we create for patients.”